{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:54:11Z","timestamp":1760547251408,"version":"3.41.2"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2002,5]]},"DOI":"10.1023\/a:1015302012070","type":"journal-article","created":{"date-parts":[[2002,12,28]],"date-time":"2002-12-28T18:08:17Z","timestamp":1041098897000},"page":"621-628","source":"Crossref","is-referenced-by-count":21,"title":["Insulin Aspart (AspB28 Human Insulin) Derivatives Formed in Pharmaceutical Solutions"],"prefix":"10.1007","volume":"19","author":[{"given":"Mette Uve","family":"Jars","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aage","family":"Hvass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorte","family":"Waaben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"372385_CR1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0169-409X(98)00079-9","volume":"35","author":"J. Brange","year":"1999","unstructured":"J. Brange and Aa. V\u00f8 lund. Insulin analogs with improved pharmacokinetic profiles. Adv.Drug Delivery Rev. 35:307\u2013335 (1999).","journal-title":"Adv. Drug Delivery Rev."},{"key":"372385_CR2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"The Diabetes ControlComplications Trial Research Group.","year":"1993","unstructured":"The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N.Engl.J.Med. 329:977\u2013986 (1993).","journal-title":"N. Engl. J. Med."},{"key":"372385_CR3","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/333679a0","volume":"333","author":"J. Brange","year":"1988","unstructured":"J. Brange, U. Ribel, J. F. Hansen, G. Dodson, M. T. Hansen, S. Havelund, S. G. Melberg, F. Norris, K. Norris, L. Snel, A. R. S\u00f8 rensen, and H. O. Voigt. Monomeric insulins obtained by protein engineering and their medical implications. Nature\n333:679\u2013682 (1988).","journal-title":"Nature"},{"key":"372385_CR4","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2337\/diacare.13.9.923","volume":"13","author":"J. Brange","year":"1990","unstructured":"J. Brange, D. R. Owens, S. Kang, and Aa. V\u00f8 lund. Monomeric insulins and their experimental and clinical implications. Diabetes Care\n13:923\u2013954 (1990).","journal-title":"Diabetes Care"},{"key":"372385_CR5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000183967","volume":"41","author":"R. D. DiMarchi","year":"1994","unstructured":"R. D. DiMarchi, R. E. Chance, H. B. Long, J. E. Shields, and L. J. Slieker. Preparation of an insulin with improved pharmacokinetics relative to human insulin through consideration of structural homology with insulin-like growth factor I. Horm.Res. 41:93\u201396 (1994).","journal-title":"Horm. Res."},{"key":"372385_CR6","doi-asserted-by":"crossref","first-page":"11516","DOI":"10.1021\/bi980807s","volume":"37","author":"J. L. Whittingham","year":"1998","unstructured":"J. L. Whittingham, D. J. Edwards, A. A. Antson, J. M. Clarkson, and G. G. Dodson. Interactions of phenol and m-cresol in the insulin hexamer, and their effect on the association properties of B28 Pro\u2192Asp insulin analogues. Biochemistry\n37:11516\u201311523 (1998).","journal-title":"Biochemistry"},{"key":"372385_CR7","first-page":"102","volume-title":"Frontiers in Insulin Pharmacology","author":"J. A. Lutterman","year":"1993","unstructured":"J. A. Lutterman, E. Pijpers, P. M. Netten, and L. N. J\u00f8 rgensen. Glycaemic control in IDDM patients during one day with injection of human insulin or the insulin analogues insulin X14 and insulin X14 (+Zn). In M. Berger and F. A. Gries (eds.), Frontiers in Insulin Pharmacology, Georg Thieme Verlag Stuttgart, Thieme Medical Publisher, Inc., New York, 1993 pp. 102\u2013109."},{"key":"372385_CR8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1046\/j.1464-5491.2000.00380.x","volume":"17","author":"P. D. Home","year":"2000","unstructured":"P. D. Home, A. Lindholm, and A. Riist. Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial. Diabet.Med. 17:762\u2013771 (2000).","journal-title":"Diabet. Med."},{"key":"372385_CR9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1015835017916","volume":"9","author":"J. Brange","year":"1992","unstructured":"J. Brange, L. Langkj\u00e6 r, S. Havelund, and Aa. V\u00f8 lund. Chemical stability of insulin: 1. Hydrolytic degradation during storage of pharmaceutical preparations. Pharm.Res. 9:715\u2013726 (1992).","journal-title":"Pharm. Res."},{"key":"372385_CR10","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1023\/A:1015887001987","volume":"9","author":"J. Brange","year":"1992","unstructured":"J. Brange, S. Havelund, and P. Hougaard. Chemical stability of insulin: 2. Formation of higher molecular weight transformation products during storage of pharmaceutical preparations. Pharm.Res. 9:727\u2013734 (1992).","journal-title":"Pharm. Res."},{"key":"372385_CR11","first-page":"149","volume":"4","author":"J. Brange","year":"1992","unstructured":"J. Brange and L. Langkj\u00e6 r. Chemical stability of insulin: 3. Influence of excipients, formulation, and pH. Acta Pharm.Nord. 4:149\u2013158 (1992).","journal-title":"Acta Pharm. Nord."},{"key":"372385_CR12","first-page":"209","volume":"4","author":"J. Brange","year":"1992","unstructured":"J. Brange. Chemical stability of insulin: 4. Mechanisms and kinetics of chemical transformations in pharmaceutical formulation. Acta Pharm.Nord. 4:209\u2013222 (1992).","journal-title":"Acta Pharm. Nord."},{"key":"372385_CR13","first-page":"223","volume":"4","author":"J. Brange","year":"1992","unstructured":"J. Brange, O. Hallund, and E. S\u00f8 rensen. Chemical stability of insulin: 5. Isolation, characterization and identification of insulin transformation products. Acta Pharm.Nord. 4:223\u2013232 (1992).","journal-title":"Acta Pharm. Nord."},{"key":"372385_CR14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jps.2600840303","volume":"84","author":"R. T. Darrington","year":"1995","unstructured":"R. T. Darrington and B. D. Anderson. Evidence for a common intermediate in insulin deamidation and covalent dimer formation: Effects of pH and aniline trapping in dilute acidic solutions. J.Pharm.Sci. 84:275\u2013282 (1995).","journal-title":"J. Pharm. Sci."},{"key":"372385_CR15","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1021\/js9700311","volume":"86","author":"R. G. Strickley","year":"1997","unstructured":"R. G. Strickley and B. D. Anderson. Solid-state stability of human insulin II. Effect of water on reactive intermediate partitioning in lyophiles from pH 2\u20135 solutions: Stabilization against covalent dimer formation. J.Pharm.Sci. 86:645\u2013653 (1997).","journal-title":"J. Pharm. Sci."},{"key":"372385_CR16","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0731-7085(99)00230-7","volume":"21","author":"D. W. Asward","year":"2000","unstructured":"D. W. Asward, M. V. Paranandi, and B. T. Schurter. Isoaspartate in peptides and proteins: Formation, significance, and analysis. J.Pharm.Biomed.Anal. 21:1129\u20131136 (2000).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"372385_CR17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1399-3011.1987.tb03390.x","volume":"30","author":"S. Clarke","year":"1987","unstructured":"S. Clarke. Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins. Int.J.Peptide Protein Res. 30:808\u2013821 (1987).","journal-title":"Int. J. Peptide Protein Res."},{"key":"372385_CR18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0021-9258(19)75855-4","volume":"262","author":"T. Geiger","year":"1987","unstructured":"T. Geiger and S. Clarke. Deamidation, isomerization and racemization at asparaginyl and aspartyl residues in peptides: Succinimide-linked reactions that contribute to protein degradation. J.Biol.Chem. 262:785\u2013794 (1987).","journal-title":"J. Biol. Chem."},{"key":"372385_CR19","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/S0021-9258(18)83327-0","volume":"264","author":"R. C. Stephenson","year":"1989","unstructured":"R. C. Stephenson and S. Clarke. Succinimide formation from aspartyl and asparaginyl peptides as model for the spontaneous degradation of proteins. J.Biol.Chem. 264:6164\u20136170 (1989).","journal-title":"J. Biol. Chem."},{"key":"372385_CR20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0021-9258(19)83984-4","volume":"238","author":"D. G. Smyth","year":"1963","unstructured":"D. G. Smyth, W. H. Stein, and S. Moore. The sequence of amino acid residues in bovine pancreatic ribonuclease: Revisions and confirmations. J.Biol.Chem. 238:227\u2013234 (1963).","journal-title":"J. Biol. Chem."},{"key":"372385_CR21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0076-6879(63)06257-1","volume":"6","author":"S. Moore","year":"1963","unstructured":"S. Moore and W. H. Stein. [117] Chromatographic determination of amino acids by the use of automatic recording equipment. Methods Enzymol. 6:819\u2013831 (1963).","journal-title":"Methods Enzymol."},{"key":"372385_CR22","first-page":"883","volume-title":"USP 24 Insulin Human, Identification B, Fingerprint Test","author":"The United States Pharmacopoeia.","year":"2000","unstructured":"The United States Pharmacopoeia. USP 24 Insulin Human, Identification B, Fingerprint Test, The United States Pharmacopeial Convention, Inc., Rockville, Maryland, 2000 pp. 883."},{"key":"372385_CR23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1432-1033.1967.tb00047.x","volume":"1","author":"P. Edman","year":"1967","unstructured":"P. Edman and G. Begg. A protein sequenator. Eur.J.Biochem. 1:80\u201391 (1967).","journal-title":"Eur. J. Biochem."},{"key":"372385_CR24","unstructured":"European Pharmacopoeia 2nd ed., v. 2.2.3. Assay of insulin, method C, 1984 pp. 3\u20134."},{"key":"372385_CR25","unstructured":"European Pharmacopoeia. Insulin preparations, injectable, No. 1999: 0854. Assay, 2000 pp. 5\u20138."},{"key":"372385_CR26","first-page":"882","volume-title":"USP 24 Insulin Injection, Assay","author":"The United States Pharmacopoeia.","year":"2000","unstructured":"The United States Pharmacopoeia. USP 24 Insulin Injection, Assay. The United States Pharmacopeial Convention, Inc. Rockville, Maryland, 2000 pp. 882\u2013883."},{"key":"372385_CR27","unstructured":"J. M. Olinger. Insulin preparations monograph proposals and rationale for modification. European Pharmacopoeia Commission, Group of Experts No.6I, Biological Standardisation Program, Insulin Specifications, Report of the international meeting held 16 February 1995, Strasbourg, 1995, pp. 12\u201328."},{"key":"372385_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3170001","volume":"317","author":"R. M. Daniel","year":"1996","unstructured":"R. M. Daniel, M. Dines, and H. H. Petach. The denaturation and degradation of stable enzymes at high temperatures. Biochem.J. 317:1\u201311 (1996).","journal-title":"Biochem. J."},{"key":"372385_CR29","doi-asserted-by":"crossref","first-page":"8522","DOI":"10.1016\/S0021-9258(18)47445-5","volume":"262","author":"I. M. Ota","year":"1987","unstructured":"I. M. Ota, L. Ding, and S. Clarke. Methylation at specific altered aspartyl and asparaginyl residues in glucagon by erythrocyte protein carboxyl methyltransferase. J.Biol.Chem. 262:8522\u20138531 (1987).","journal-title":"J. Biol. Chem."},{"key":"372385_CR30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1515\/bchm3.1987.368.2.903","volume":"368","author":"A. Wollmer","year":"1987","unstructured":"A. Wollmer, B. Rannefeld, B. R. Johansen, K. R. Hejnaes, P. Balschmidt, and F. B. Hansen. Phenol-promoted structural transformation of insulin in solution. Biol.Chem.Hoppe-Seyler\n368: 903\u2013911 (1987).","journal-title":"Biol. Chem. Hoppe-Seyler"},{"key":"372385_CR31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/anie.199005653","volume":"29","author":"F. Ledl","year":"1990","unstructured":"F. Ledl and E. Schleicher. New Aspects of the Maillard reaction in foods and in the human body. Angew.Chem.Int.Ed.Engl. 29:565\u2013594 (1990).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"372385_CR32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1021\/bk-1990-0434.ch006","volume-title":"Analytical Biotechnology Capillary Electrophoresis and Chromatography","author":"R. M. Riggin","year":"1990","unstructured":"R. M. Riggin and N. A. Farid. Analytical chemistry of therapeutic proteins. In C. Horv\u00e1th and J. G. Nikelly (eds.), Analytical Biotechnology Capillary Electrophoresis and Chromatography, American Chemical Society, Washington, DC, 1990 pp. 113\u2013126."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015302012070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1015302012070\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015302012070.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T08:53:17Z","timestamp":1754038397000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1015302012070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["372385"],"URL":"https:\/\/doi.org\/10.1023\/a:1015302012070","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"type":"print","value":"0724-8741"},{"type":"electronic","value":"1573-904X"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}